TY - JOUR T1 - Occurrence, fate, and risk assessment of antibiotics in typical pharmaceutical manufactories and receiving surface waters from different regions JF - medRxiv DO - 10.1101/2022.06.22.22276743 SP - 2022.06.22.22276743 AU - Yuanfei Liu AU - Dan Cai AU - Xin Li AU - Qingyao Wu AU - Ping Ding AU - Liangchen Shen AU - Jian Yang AU - Guocheng Hu AU - Jinhua Wu Y1 - 2022/01/01 UR - http://medrxiv.org/content/early/2022/06/27/2022.06.22.22276743.abstract N2 - This study aimed to update information on the presence and persistence of antibiotics in wastewater from four typical pharmaceutical plants in China and the removal of antibiotics by the wastewater treatment process. It also evaluated the environmental impact of antibiotic residues through wastewater discharge into receiving water bodies. The results indicated that 13 antibiotics were detected in wastewater samples with concentrations ranging from 57.03 to 726.79 ng/L. Fluoroquinolones (FQs) and macrolides (MLs) were the most abundant antibiotic classes in wastewater samples, accounting for 42.5% and 38.7% of total antibiotic concentrations, respectively, followed by sulfonamides (SAs) (16.4%) and tetracyclines (TCs) (2.4%). Erythromycin-H2O (ERY), lincomycin (LIN), ofloxacin (OFL), and trimethoprim (TMP) were the most frequently detected antibiotics; among these antibiotics, the concentration of OFL was the highest in most wastewater samples. No significant difference was found in the removal of antibiotics between different treatment processes, and more than 50% of antibiotics were not completely removed with a removal efficiency of less than 70%. The concentration of detected antibiotics in the receiving water was an order of magnitude lower than that in the wastewater due to dilution. Finally, an environmental risk analysis showed that lincomycin and ofloxacin could pose a high risk at the concentrations detected in effluents and a medium risk in their receiving waters, highlighting that they were a potential hazard to the health of the aquatic ecosystem.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was financially supported by the National Key Research and Development Program of China (2018YFC1801505), the National Science Foundation for Distinguished Young Scholars of China [42107468], the Guangzhou Municipal Science and Technology Project [201804010193, 202240070007], and the Special Basic Research Fund for Central Public Research Institutes of China [PM-zx097-202104-089, PM-zx703-202204-179].The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Not ApplicableAll relevant data are within the manuscript and its Supporting Information files. ER -